Denosumab versus zoledronic acid for preventing symptomatic skeletal events in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer: An outcome analyses with a mean follow-up of 3 years

Định dạng: PDF / Số trang: 9

Nhắn tin với admin nếu không tải được